Labcorp Holdings Inc. closed 9.72% below its 52-week high of $258.59, which the company reached on March 5th.
Labcorp (LH) will offer nationwide an FDA-approved human papillomavirus self-collection solution that can help women and their physicians asses ...
The stock's rise snapped a four-day losing streak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback